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Summary
 
Immunoglobulin (Ig) genes expressed in mature B lymphocytes can undergo somatic hyper-
mutation upon cell interaction with antigen and T cells. The mutation mechanism had previ-
ously been shown to depend upon transcription initiation, suggesting that a mutator factor was
loaded on an RNA polymerase initiating at the promoter and causing mutations during elonga-
tion (Peters, A., and U. Storb. 1996. 
 
Immunity.
 
 4:57–65). To further elucidate this process we
have created an artificial substrate consisting of alternating EcoRV and PvuII restriction en-
zyme sites (EPS) located within the variable (V) region of an Ig transgene. This substrate can
easily be assayed for the presence of mutations in DNA from transgenic lymphocytes by ampli-
fying the EPS insert and determining by restriction enzyme digestion whether any of the re-
striction sites have been altered. Surprisingly, the EPS insert was mutated many times more fre-
quently than the flanking Ig sequences. In addition there were striking differences in mutability
of the different nucleotides within the restriction sites. The data favor a model of somatic hy-
permutation where the fine specificity of the mutations is determined by nucleotide sequence
preferences of a mutator factor, and where the general site of mutagenesis is determined by the
pausing of the RNA polymerase due to secondary structures within the nascent RNA.
Key words: Ig genes • somatic hypermutation • RNA secondary structure • hot spots • RNA 
polymerase pausing
 
T
 
he diversity of immunoglobulin variable regions is
created from the germline variable (V),
 
1
 
 diversity (D),
and joining (J) gene sequences by V(D)J recombination and
somatic hypermutation. The latter is initiated when a ma-
ture B lymphocyte interacts with specific antigen and T
lymphocytes in a germinal center response (1, 2). The B
cell undergoes Ig gene mutation during several rounds of
rapid proliferation and is subsequently selected for func-
tional antibody production by interaction with antigen
bound to follicular dendritic cells (1, 2).
The mechanism of somatic hypermutation is not under-
stood. The mutations are mainly point mutations with very
rare deletions and even rarer insertions (3). Mutations are
found from near the start of the gene and occur over
 
z
 
1.5–2 kb. The 3
 
9
 
 region of the gene, including the con-
stant (C) region, is generally not mutated (4). Transcription
of the Ig gene is required (5, 6). We have determined re-
cently that duplication of the Ig promoter upstream of the
C region leads to transcription from this internal site and
somatic mutations in the C region at a similar frequency as
in the V region (7). The region upstream of the duplicate
promoter is not mutated. Based on these data, we proposed
a model of somatic hypermutation where a mutator factor
(MuF) becomes associated with the RNA polymerase at an
Ig promoter that is interacting with an Ig enhancer (7, 8).
Whereas the general model of coupling somatic muta-
tion to the transcription of an Ig gene is most likely correct,
the mechanism of how the mutations arise during tran-
scription elongation is not known. We had postulated that
the MuF causes pausing of the elongating RNA poly-
merase and that the paused complex is treated like a lesion
in the DNA, eliciting a transcription coupled repair mech-
anism (7, 8). However, we now know that many proteins
required for two major mechanisms of transcription coupled
repair, nucleotide excision repair and mismatch repair, are
not required for somatic hypermutation (9–15; Kim, N.,
and U. Storb, unpublished data). Although there are possi-
 
1
 
Abbreviations used in this paper:
 
 C, constant; D, diversity; EPS, alternating
EcoRV and PvuII restriction enzyme sites; J, joining; MuF, mutator fac-
tor; pol, RNA, polymerase II; V, variable.
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bly other mechanisms of transcription-coupled repair that
play a role in somatic hypermutation, this aspect of the
model may have to be modified.
To further investigate the molecular mechanism respon-
sible for somatic hypermutation of Ig genes, we created an
artificial mutation substrate which has an unusual repeat
structure containing seven EcoRV restriction sites alternat-
ing with six PvuII sites inserted into the middle of the V
region of an Ig
 
k
 
 transgene (16). As reported here, the anal-
ysis of the restriction enzyme site repeats has revealed that
they are hypermutable relative to the flanking Ig sequences
and has provided new clues to the mechanism of somatic
hypermutation.
 
Materials and Methods
 
Production of PEPS4 Transgenic Mice, Immunization, and Isolation
of PNA
 
hi
 
, B220
 
1
 
 B Cells.
 
These methods were performed as
previously described (16).
 
Cloning and EPS Analysis of the PEPS4 Transgene.
 
The trans-
genes were cloned from the DNA of B220
 
1
 
 PNA
 
hi
 
 FACS
 
Ò
 
-
sorted spleen cells of mice immunized with sheep red blood cells
by amplification with PFU DNA polymerase (Stratagene, La
Jolla, CA) using JRH2 (5
 
9
 
-GACCACGCTACCTGCAG) as the
3
 
9
 
 primer (see Fig. 1 
 
B
 
). The 5
 
9
 
 primer was Vmu
 
1
 
1 (5
 
9
 
-
CCTGGGGGTGCTTATGTTCTAGATCTCTGG). The PCR
products were digested with BglII (New England Biolabs Inc.,
Beverly, MA). The 5
 
9
 
 BglII sites (underlined) were introduced by
a single base change from the transgenic sequence. The BglII
fragment was cloned into the BamHI site of pUC18. Clones
were screened for the presence of mutations within the EPS frag-
ment by amplification with Taq DNA polymerase using EKVK1
(5
 
9
 
-ATTTGATGTCCACCCGTG) and EKVK2 (5
 
9
 
-TCA-
ACTGATAATGAGCCCTC) or Vk8B (5
 
9
 
-GTTTCAGCT-
CCAGCTTG) and Vk9B (5
 
9
 
-CTCCTCAGCTCCTGATC) for
30 cycles of 94
 
8
 
C 15 s, 60
 
8
 
C 20 s, 72
 
8
 
C 30 s. The PCR product
was digested with either EcoRV or PvuII. The samples were run
on an 18% acrylamide/5% glycerol gel that was subsequently
stained with ethidium bromide. Amplifications were repeated to
confirm that the mutations detected were not due to Taq DNA
polymerase errors.
 
Sequencing of the EPS and Flanking Transgenic DNA.
 
To con-
firm the mutations within the restriction enzyme sites and to
identify flanking mutations, the cloned transgenes were se-
quenced using Sequenase Version 1.0 and the dGTP Nucleotide
Kit. For manual sequencing combinations of the following primers
(see Fig. 1 
 
B
 
) were used: 1233, 1224, 1212 (New England Biolabs
Inc.), EKVK1, EKVK2, EPSAS (5
 
9
 
-ATACACACCCACATC-
CTCAGCC), Vk7 (5
 
9
 
-GAGTGAAGGCTGAGGATGTG),
JRH1 (5
 
9
 
-GATGTAGATTCAGGTGC), seq4 (5
 
9
 
-CAGGAG-
CTGAGGAGATTGTC), and Vk10A (5
 
9
 
-CTGCAGGAG-
ATGGAAAC). A subset of the sequences were obtained by auto-
mated sequencing with dye terminators using a ABI Prism model
377 sequencer. The sequencing primers were V
 
k
 
234 (5
 
9
 
-
TGATGGCCCAGATGATTCCTA) and V
 
k
 
950(5
 
9
 
-GAGCCC-
TCTCCATTTTCTCAAGAT).  Both strands were sequenced
and analyzed with the Macintosh version 3.0 of Sequencher
(GeneCodes, Ann Arbor, MI).
 
Mutability Quotient.
 
This represents the observed/expected
ratio of mutations in dinucleotides (see Fig. 4), or trinucleotides
(see Figs. 3 and 4) as tabulated in Tables II and III (columns A/J 
 
1
 
Literature), respectively, in Smith et al. (17). The data in Smith et
al. (17) were obtained from J
 
k
 
 and JH 3
 
9
 
 flanking sequences that
could not be selected because they do not code for protein se-
quences.
 
Results
 
The EPS Transgene.
 
Several transgenic lines were pro-
duced with the EPS transgene (16). One line, PEPS4, con-
taining three to four copies of the transgene, is the subject
of this report. The nucleotide sequence of the 108 base
EPS and a diagram of its placement within the Ig 
 
k
 
 trans-
gene are shown in Fig. 1 
 
A
 
. Amplification with flanking
primers (Fig. 1 
 
B
 
) and complete digestion with either
EcoRV or PvuII results in two larger fragments and a lad-
der of small DNA fragments (Figs. 1 
 
C
 
 and 2). Fig. 2 shows
an example of the PCR products for 10 transgene clones
obtained from PNA
 
hi
 
 B lymphocytes (germinal center B
cells) of a PEPS4 mouse. Digestion with EcoRV or PvuII
results in two larger bands representing the 5
 
9
 
 and 3
 
9
 
EcoRV and PvuII fragments, respectively (the smaller [5
 
9
 
]
and larger [3
 
9
 
] bands on top of the gel in Fig. 2, respec-
tively). In addition, the EcoRV digestion results in frag-
ments of 10, 12, 14, 16, 18, and 20 base pairs in length, and
the PvuII digestion gives fragments of 11, 13, 15, 17, and
19 base pairs in length. The smaller fragments (underlined)
are not visible on the gel, presumably due to melting of the
DNA strands. Loss of one of the restriction sites due to a
point mutation will result in the loss of two smaller bands
and the appearance of a larger band. For example, clone G8
at the right end of the gel, has both an EcoRV and a PvuII
mutation. Changes in the first Eco or Pvu sites at the 5
 
9
 
end of the cluster lead to a size increase of the smaller frag-
ment at the top of the gel. 76 bases of the EPS lie within
restriction sites and thus, mutation of these bases are detect-
able by digestion. The restriction sites are labeled by letter
(Fig. 1 
 
C
 
), thus the EcoRV site mutated in clone G8 is site
EF and the PvuII site is site PE (compare Fig. 2 with Fig. 3).
 
Somatic Hypermutation in the EPS Transgene.
 
In a DNA
preparation obtained from the PNA
 
hi
 
 cells of a hyperim-
munized PEPS4 mouse, on average 1 in 19 clones showed
a change in an EPS restriction enzyme site (see below).
Clones mutated in the EPS were sequenced, including
 
z
 
500 NTs of flanking sequence. Fig. 3 summarizes the
mutations in the EPS and the flanks. Sequencing confirmed
all the mutations that had been observed within the
EcoRV or PvuII sites by gel electrophoresis of PCR ampli-
fied DNA. In addition, five mutations were found between
the restriction sites in the EPS. 27 of 46 clones also con-
tained one or more mutations in the flanking regions.
Strikingly, nucleotides in the EPS region on average were
mutated seven times more frequently (17 
 
6 
 
8.6 mutations/
1,000 NTs) than those in the flanks (2.3 
 
6 
 
3.5 mutations/
1,000 NTs). The seven mutations found between the re-
striction sites in the EPS (Fig. 3) were included in the EPS
mutations since these sites were mutated at a frequency
more similar to that of the average nucleotide within the
restriction sites than those within the flanks. The frequency 
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of mutations in the flanks is similar 5
 
9
 
 and 3
 
9
 
 of the EPS.
The hypermutability of the EPS is also apparent in individ-
ual transgene copies; 19 of 46 clones have 1–3 mutations in
the EPS, but none in the flanks. The highest EPS/flank mu-
tation ratio was 
 
.
 
31.3. Only one clone had the same muta-
tion frequency in the flank and EPS (6 mutations/574 NTs
in the flank and 1 mutation/96 NTs in the EPS). In all
other clones the EPS is mutated at least 2.5
 
3
 
 more than the
flank. 13 of 46 clones have more than one mutation in the
flank. 10 of these have more than one mutation in the EPS.
One mutation in the flanks, position 534, was found to
be mutated from G to A in about one of three sequenced
clones. This mutation was considered to be a germline mu-
tation. The frequency of its occurrence in one-third of the
clones supports the transgene copy number of about four
determined by Southern blotting of genomic DNA from
the PEPS4 transgenic line (16). The transgene copies with
G at position 534 were named copy A, the ones with A
were named copy B. The mutation frequency in A and B
copies is about the same (not shown).
None of the EPS mutations are likely to be a germline
mutation, because in 
 
.
 
200 DNA clones obtained from
two batches of nonimmune B cells analyzed by restriction
enzyme analysis, none were found to be mutated (not
shown). These large numbers of unmutated transgene se-
quences also show that the EPS is not generally hypermut-
able, but that EPS mutations occur only in the context of
somatic hypermutation accompanying immunization.
The data presented here are from one PEPS4 mouse.
Similar results were obtained in a small sample of sequences
from another PEPS4 mouse, and from a different mouse,
PEPS 3 (not shown). As with all transgenes, position effects
can be important: some other transgenic lines carrying the
same insert in a 
 
k
 
 transgene show low or no detectable mu-
tations in the EPS or the flanking sequences (16).
 
Are the Transgenes without EPS Mutations Mutated in the
Flanking V/J Region?
 
To understand the impact of the ar-
tificial EPS sequence on the process of somatic mutation it
was important to know if the transgene copies that lacked
mutations within the EPS contained mutations in the
flanking regions. Sequencing was carried out on 10 clones
Figure 2. PAGE of EPS PCR products from 10 clones digested with
PvuII or EcoRV. The EPS in B1 and A1 is not mutated. P, PvuII; E,
EcoRV.
Figure 1. Maps of the EPS transgene and primers. (A) The EPS transgene and sequence of the EPS insert (not to scale). (B) The EPS transgene from
the leader to the 59 end of the J-C intron. Primers used for cloning and sequencing are shown below the transgene. (C) Maps of the EcoRV and PvuII
sites within the EPS. Numbers indicate distances between the cut sites. 
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from PNA
 
hi
 
 cells that had shown no EPS mutations by
PCR/restriction enzyme analysis. A region of 
 
z
 
700 bp
was sequenced that encompassed the 3
 
9
 
 250 bp of the L-V
intron, the V region (300 bp), the EPS (108 bp), the J re-
gion (37 bp), and the first 30 bases of the J-C intron. None
of the clones contained any mutations, either in the EPS or
in the flanks (not shown).
To assess the probability of the existence of clones that
might be highly mutated in the flanks but not in the EPS,
the sequencing information from mutated and unmutated
clones was submitted to a statistical analysis. Because it was
prohibitive to sequence the V/J regions for all clones un-
mutated in the EPS, and because most of the clones se-
quenced were not a random subsample, but had EPS muta-
tions, we were unable to use standard statistical methods to
test the null hypothesis that the mutation rate was the same
in the EPS as in the flank. Therefore, the following simula-
tion was performed. First, a negative binomial model was
Figure 3. Mutations in the EPS and flanks. The original transgene sequence from NT 290–900 is shown in uppercase letters; below it in lower case
letters are the observed mutations from all 46 sequences. The restriction sites within the EPS are indicated (E, EcoRV; P, PvuII; the seven Eco and six
Pvu sites are labeled A–G and A–F, respectively). 33, mutations in the EA site were found by restriction analysis in three clones that were lost before
DNA sequencing could be performed; since in these clones the PA site was not mutated, the mutations can only be in position 1–5 of EA; the 6 muta-
tions in EA are excluded from Fig. 4, but included in Fig. 6. The symbols below each sequence indicate the mutability quotient (MQ; see Materials and
Methods) of the trinucleotide starting at the indicated NT (after reference 17). MQ symbols above the line: high column 5 very high MQ ($1.44), low
column 5 high MQ (1.36–1.43); MQ symbols below the line: high column 5 very low MQ (#0.60), low column 5 low MQ (0.68–0.61); no symbol:
MQ 0.69–1.35 (i.e., the observed mutability does not differ greatly from the expected mutability). 
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fit to the observed distribution of the number of mutations
within the 96 nucleotides of the EPS using the data from
the first 466 clones (24 with EPS mutations, and the rest
without). This model may be viewed as a two-step process
by which a different mutation rate for each clone is first
chosen from an underlying 
 
g
 
 distribution (a family of prob-
ability distributions taking only positive values), and then
mutations on each clone occur randomly according to a
Poisson process with the chosen rate. A comparison of the
observed distribution of mutations within the 96 NTs of
the EPS to that predicted by the negative binomial model
suggests that the model provides a reasonable fit to the data.
We then used the fitted model to randomly generate
data for 466 hypothetical clones. The number of mutations
in the V/J regions were generated according to a Poisson
process with the same rate as in the corresponding EPS re-
gion. Thus, the model reflects the null hypothesis that the
mutation rate for each clone is the same in the EPS as in
the flank. As in the actual data, a subsample was then cho-
sen by taking all clones for which there was at least one
EPS mutation and a random subsample of 10 of the re-
maining clones. The difference in the observed mutation
rates between the EPS and the flank was then computed
using only this subsample. This process was repeated
10,000 times.
In none of the 10,000 repetitions did we observe a dif-
ference between the EPS and flank as large as that observed
in our data. Thus, we may conclude that the statistical anal-
ysis provides strong evidence that the mutation rates in the
two regions are different (details available upon request).
Thus, the statistical analysis leads to the conclusion that the
EPS is mutated at a higher rate than the flanks and that most
of the DNA clones that did not show mutations in the EPS
also would not contain mutations in the flanks. This sug-
gests that within this transgene, the EPS is a hypermutable
sequence (see below). It appears likely that the transgene
copies that did not show any mutations were from cells in
which the mutation mechanism was not activated.
 
Differential Mutability of Different Nucleotides within the EPS
Sequence.
 
There is a clear bias in the nucleotides within
each restriction site within the EPS that are targeted for
mutation (Fig. 4). The G and C in positions 3 and 4 of the
PvuII site and the T and A in positions 3 and 4 of the
EcoRV site are the most highly mutable nucleotides. The T
and G in positions 5 and 6 of the PvuII site are the least mu-
tated. All sequenced PvuII and EcoRV sites show these dif-
ferential mutabilities, regardless of their position within the
repeats (Fig. 3).
 
Discussion
 
The EPS sequence is hypermutable compared with the
flanking V and J regions. This is apparent for the individual
transgenes analyzed copies as well as for the total sample.
Because of its ease of analysis, this artificial mutation sub-
strate will be a useful test substrate in combination with Ig
transgenes to define more completely the 
 
cis
 
-acting control
elements and transacting factors required for somatic muta-
tion. Furthermore, modifications of the EPS will permit a
more refined analysis of the DNA sequence and overall
structure that is conducive to hypermutability.
 
The Position of Mutations within the Restriction Sites Reflects
Preferences of a MuF.
 
The six nucleotides within the EcoRV
or PvuII sites, respectively, are not mutated at an equiva-
Figure 4. Relationship of mu-
tations to hydrogen bonds and
mutability of di- and trinucle-
otides within the EcoRV and
PvuII sites. The columns show
(black) the number of mutations
from Fig. 3 in the EcoRV sites
(EB to EG) and PvuII sites (PA
to PF); (gray) the hydrogen
bonds between the unmutated
restriction site NTs G/C, C/G,
A/T, and T/A base pairs. Below
the graph are shown the muta-
bility quotients (MQ; see Mate-
rials and Methods) of somatic
mutations in di- and trinucle-
otides from a large database of
normal Ig gene mutations (17).
The numbers for dinucleotides
are placed between two NTs in
the EPS dinucleotide; the num-
bers for trinucleotides are placed
below the central NT in the EPS
trinucleotide. Bold numbers: the
MQ is greatly higher than 1 (see
legend Fig. 3). * Numbers: the
MQ is greatly lower than 1. The
first and last NT written in parentheses is the most frequent flanking NT. In the calculation of the MQ for given di- or trinucleotides of the first or last
NTs, the MQs were averaged for all flanking NTs. The white boxes above the first G in the EcoRV site and the last G in the PvuII site indicate a NT
that is overlapping both sites between PA and EB (see Fig. 1).694 Role of Hotspots and RNA Hairpins in Somatic Hypermutation of Ig Genes
lent frequency. There is a preference for G3 and C4 in the
Pvu site and T3 and A4 in the Eco site. In addition, the 39
terminal nucleotides in the Pvu site are rarely, if at all, mu-
tated. The mutability does not correlate with the strength
of hydrogen bonding of the individual nucleotides (Fig. 4):
three hydrogen bonds can form in a G/C (C/G) base pair,
and only two between A/T (T/A). Furthermore, if the en-
ergy of pairing between like restriction sites were the cause
for the preferential nucleotide mutability, the mutations
would be expected to be symmetrical across each restric-
tion site. Clearly this is not the case (Fig. 4).
Another possibility is that the restriction sites themselves,
being palindromic in nature, may be the direct targets for
somatic mutation. We believe this to be unlikely because
then the nonpalindromic sequences between the restriction
sites should not be more highly mutable than the flanking
Ig sequences, but they are. Also, the mutations should be
symmetrical across each restriction site, but they are not.
Similarly, Goyenchea and Milstein (18) found that shorten-
ing a palindrome to a length where it cannot form a stem/
loop anymore does not alter the hypermutability of a
hotspot.
However, there is a good correlation between the muta-
bility of individual EPS nucleotides and the sequence of
known hotspots of somatic hypermutation (17, 19, 20).
Smith et al. (17) compiled data of somatic mutations in the
39 flanks of functionally rearranged Jk genes. These se-
quences are outside of the Ig coding region and therefore
are not selected based on protein function. Fig. 4 shows a
comparison of the EPS mutations with the mutability of di-
nucleotides and trinucleotides from natural immunoglobu-
lin genes surveyed by Wysocki et al. (17). The two most
highly mutated nucleotides in both the Pvu and Eco sites
are partners in dinucleotide and trinucleotide combinations
that are preferentially mutable in Ig genes (17). Interest-
ingly, the three positions in the trinucleotides AGC and
GCT that occur in the center of the PvuII site were found
to be mutated in the Wysocki survey in the following or-
der: A , G , C; G , C .. T. These are exactly the rel-
ative mutabilities found in the PvuII sites of the EPS. On
the other hand, the less mutated residues are within dinu-
cleotides and trinucleotides that are disfavored for somatic
hypermutation.
We propose from these comparisons that the frequently
and rarely mutated sites within the EPS reflect preferences
of a postulated MuF (see below).
The Hypermutability of the EPS Over the Flanking Sequences
Appears to Be Related to RNA Secondary Structure. The most
highly mutable trinucleotides in the EcoRV and PvuII se-
quences are among the most highly mutable trinucleotides
in conventional Ig genes (17). To determine whether their
concentration was significantly higher within the EPS than
in the flanks, we have tallied the mutability of all trinucle-
otides over 600 NTs of flanks and EPS (Fig. 3 and Table
1). The EPS containing NTs 608–707 have a slightly
higher number of trinucleotides with a very high mutabil-
ity quotient than the flanking sequences 408–507 and 808–
907 (Table 1). They also have a smaller number of trinucle-
otides with a very low mutability quotient than these two
stretches flanking sequences, but they are mutated 6 and 11
times more highly. Although currently it is not possible to
quantitatively assess the relative importance of the various
hotspots and coldspots for mutability, given these small dif-
ferences in mutability quotients it seems unlikely that they
alone are responsible for the hypermutability of the EPS.
Furthermore, there are several regions of very hot trinucle-
otides in the flanks that are not mutated, but every hotspot
is mutated in the EPS (Fig. 3). These findings suggest that
besides the primary sequence something inherent in the
overall structure of the EPS may induce hypermutability.
It appeared possible that the repeated restriction sites that
can form high stability RNA stems (and DNA stems, see
below) may play a role. We have used the Mfold program
(21) as adapted to the Wisconsin Package to scan the pre-
dicted structures for the nascent RNA that would be syn-
thesized across the EPS and sequenced flanks. A reiterative
Table 1. Mutability of EPS Transgene
NT sequence
Mutability Quotient
Mutations Very low (#0.60) Total low (#0.68) Total high ($1.36) Very high ($1.44)
308–407 30 37 32 20 22
408–507 31 40 28 25 12
508–607 37 50 14 11 7
608–707 26 26 30 30 78
708–807 29 32 22 17 8
808–907 33 37 25 23 7
The first column shows the 100 NTs analyzed in each row (see Fig. 3). Columns 2–5 show the number of trinucleotides in each sequence that have
the mutability quotient (see Materials and Methods) shown at the top of the column (after Table III in reference 17). In bold are the data for the 100
NTs that include the EPS.695 Storb et al.
application of Mfold (Martin, T.E., and D. Wang, unpub-
lished) can conveniently scan the predicted folding energies
for various RNA sequence windows at chosen NT steps
across the sequences, possibly approximating the way the
transcription machinery would encounter nascent RNA
structures. Determination of the folding energies around
the predicted energy minima (largest values of 2DG) for
windows of 20, 30, 40, 50, 60, 70, 80, 90, and 100 NTs
suggested that 50 NTs gave favorable signal-to-noise values
(not shown). The data shown in Fig. 6 are derived from
scans using a 50 NT window and 5 NT steps (an example
structure is shown in Fig. 5).
Clearly, there is a strong increase in the predicted stem
formation (as large negative energies) within the EPS com-
pared with the flanks. Interestingly, the rise and peak in the
predicted stabilities of RNA secondary structures is shifted
39 by z40 nucleotides relative to the rise and peak of the
mutations. DNA stem-loop structures have been proposed
to be targets for somatic mutation (20, 22). From our data
we conclude, instead, that stem-loops act as structures that
cause RNA polymerase pausing (see below).
A Model for Somatic Hypermutation. Previous work has
shown that somatic hypermutation is linked to transcrip-
tion initiation (7). When the Ig promoter upstream of the
V region was duplicated upstream of the C region, muta-
tions were also observed over the C region, but not be-
tween V and C. The frequency of mutations was similar in
the V and C regions, as were the numbers of transcripts
originating from the upstream and downstream promoters.
Based on these findings we have proposed that a MuF asso-
ciates with the RNA polymerase and during transcription
elongation causes mutations (7). How the mutations are in-
troduced is not known; however, the data presented here
have given new clues for the mutation mechanism. Two
major predictions for somatic hypermutation can be pro-
posed from the results reported in this paper. First, the exact
nucleotide changes depend on the nucleotide preferences
of the MuF that is specific for the somatic hypermutation
of Ig genes. Second, the overall region where point muta-
tions occur may be determined by the secondary structure
of the nascent RNA (or perhaps DNA). These findings have
led to the model shown in Fig. 7.
The postulated MuF associates with RNA polymerase II
(pol) that is initiating transcription at an Ig gene promoter
(Fig. 7 a). MuF binding to pol is only possible when certain
Figure 5. One example of the determination of the predicted energy of
RNA folding in a 50 NT window from a reiterative scanning of the
Mfold program. The nascent RNA is reportedly paired with the tran-
scribed DNA for 2–12 NTs (26), or 9–10 NTs (27). Upstream of this
DNA/RNA hybrid a potential RNA double stem of high predicted sta-
bility may arrest the elongating RNA polymerase located at the 39 end of
the nascent RNA (see Fig. 7).
Figure 6. Mutations and RNA stem formation energies. (A) Muta-
tions. NTs 290–900 from the start of the leader peptide sequence are
shown (data are shown in Fig. 3). Numbers of point mutations in intervals
of 10 nucleotides were summed. NTs 590 and 610/620 indicate the start
and peak of the EPS related hypermutability, respectively. The EPS com-
prises nucleotides 608–703. (B) Energy. An example of a predicted RNA
secondary structure and its folding energy is shown in Fig. 5. The RNA
folding energies (expressed as negative numbers) were determined for the
transgene sequence from position 290–900 for a window of 50 nucleotides
at 5 nucleotide intervals. For the plot, energies of 10 nt intervals were de-
rived by averaging the energies from three readings of the most 39 positions
within 65 nucleotides of the plotted position. The start and peak of the
EPS-related energy is indicated as 630 and 650/660, respectively.696 Role of Hotspots and RNA Hairpins in Somatic Hypermutation of Ig Genes
(unknown) enhancer binding proteins have interacted with
the basal transcription machinery (23). During transcript
elongation MuF travels with pol (Fig. 7 b). If pol encoun-
ters a block to transcription (shown is a hairpin in the nas-
cent transcript), it pauses (Fig. 7 c). The conformation of
the polymerase changes, resulting in the transfer of MuF to
the DNA (Fig. 7 d).
How the MuF then induces mutations is rather specula-
tive, but a testable possibility is that MuF binds to double
stranded DNA upstream of pol (Fig. 7 e). MuF causes a
nick in the nontranscribed strand, it remains associated with
the newly created 59 end and also with one or several nu-
cleotides on the transcribed strand (Fig. 7 f). Because of the
bound MuF, the single stranded ends cannot be ligated.
Exonuclease trims back the single stranded 39 end (Fig. 7 g).
A DNA polymerase fills in the gap creating mutation(s)
(Fig. 7, x) opposite the MuF associated base(s) (Fig. 7 h).
The DNA polymerase continues past the MuF bound resi-
dues, creating a 59 flap of the nontranscribed strand (Fig. 7 i).
The flap is cut by endonuclease Fen1 (DNase IV; refer-
ences 24, 25). The free DNA ends are ligated. MuF has
been removed with the flap (Fig. 7 j).
Most of the proposed steps are hypothetical, but all are
compatible with previous observations and the results of
the present study. The Ig promoter can be replaced with
certain other promoters, but the Ig enhancer appears to be
required for high mutability of Ig genes (5, 6). The postu-
lated MuF would only be produced during the short win-
dow in the life of the B cell when somatic hypermutation is
ongoing. It can only bind to pol initiating at a promoter
that is activated by transcription factors bound to the Ig en-
hancer, or bound to motifs shared with the Ig enhancer
(23), not randomly with pol or DNA.
During transcript elongation, pol may stop transcription
without releasing the transcript (26). Such pausing is pre-
sumably due to secondary structure of the template or hair-
pins formed in the nascent RNA (26). The EPS or its nas-
cent transcript is an array of multiple repeats that can form
very stable stem-loops (Figs. 5 and 6). Similar, but less fre-
quent repeats are present in natural Ig genes. Transcription
through a region that is transcribed into RNA that can form
hairpins is prone to becoming stalled. The pause inducing
structure is most likely an RNA hairpin, at least in the EPS,
rather than a DNA hairpin. The DNA transcription bubble
comprises only z15 single stranded NTs (27). In order for
two identical restriction sites in the EPS DNA to hybridize,
16 to 26 nucleotides are required to be single stranded in
the transcription bubble. In natural Ig genes pausing may be
due to either DNA or RNA secondary structure (26). Dur-
ing pausing the conformation of pol appears to change,
presumably under the influence of elongation factors (28,
29). We propose that only when transferred by a pol with
such an altered conformation can MuF bind to DNA. Since
the profile of mutagenesis is shifted by z40 nucleotides 59
with respect to the pattern of predicted RNA secondary
structure stabilities (Fig. 6, A and B) the MuF appears to be
deposited on the DNA z40 nucleotides upstream of the
paused pol.
We propose that the mutations may arise due to errors
made during repolymerization of the excised single stranded
region when the polymerase is copying a base to which the
MuF is bound on the template strand. There appear to be
clear target preferences, e.g., for certain NTs within di- or
trinucleotides (Fig. 4). These preferences could represent
sites at which the MuF prefers to nick the DNA, sites at
which the MuF prefers to bind on the opposite strand, thus
modifying the template for the DNA polymerase, or sites
which when combined with the MuF make the DNA
polymerase most error prone. These questions need to be
addressed in future studies.
At the end of the reaction the MuF would be removed
with the short DNA segment. We suggest that the MuF
would not be able to reload on the RNA polymerase in the
elongation mode, as it can only bind to pol that is initiating
transcription. This mode of MuF/pol interaction is sug-
gested by the loading of mRNA cleavage/polyadenylation
factors to initiation competent pol (30). The requirement
for loading MuF to an initiating pol, coupled with a high
chance for pausing within the first 1 kb or so of transcribed
DNA, explains the extent of somatic hypermutations over
only 1–2 kb of the 59 region of the Ig gene with sparing of
the 39 region (reviewed in reference 3).
Figure 7. Model of somatic hypermutation of Ig genes. MuF, mutator
factor; E, Ig enhancer; IEBP, Ig enhancer binding proteins; pol, RNA
polymerase II; exo, DNA exonuclease; x, point mutation; Fen1, flap en-
donuclease 1.697 Storb et al.
In the PEPS4 transgene (and others described in refer-
ence 16 the EPS sequence is inserted in the middle of the V
region. Presumably, insertion at another position may in-
crease or decrease the differential mutability between EPS
and flanks, depending on the secondary structures formed
in the nascent RNA. These questions can be addressed by
further studies with the artificial substrate EPS or modifica-
tions thereof.
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